Sort   by:  
 Page size 
UnknownIn vitro anti-influenza potential of glyceroglycolipids from cyanobacteria Limnospira fusiformis.
Not available
S-EPMC12418776 | biostudies-literature
UnknownGenetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease.
Not available
S-EPMC9222927 | biostudies-literature
UnknownThe Tomato DOF Daily Fluctuations 1, TDDF1 acts as flowering accelerator and protector against various stresses.
Not available
S-EPMC5578996 | biostudies-literature
UnknownMolecular characterization of a Novel NAD+-dependent farnesol dehydrogenase SoFLDH gene involved in sesquiterpenoid synthases from Salvia officinalis.
Not available
S-EPMC9165828 | biostudies-literature
UnknownHPLC-DAD-MS Characterization, Antioxidant Activity, α-amylase Inhibition, Molecular Docking, and ADMET of Flavonoids from Fenugreek Seeds.
Not available
S-EPMC10708475 | biostudies-literature
UnknownContemporary hybridization among Arabis floodplain species creates opportunities for adaptation.
Not available
S-EPMC12780310 | biostudies-literature
UnknownCytogenetic prognostication within medulloblastoma subgroups.
Not available
S-EPMC3948094 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
Sort   by:  
 Page size